Fiche société
Zhejiang University
Traitements, essais et publications liés.
Traitements5programmes
Essais3liés
Publications5liées
SourceDBlocale
Traitements
5| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| PrednisoneThe purpose of this study is to evaluate the efficacy and tolerability of prednisone in patients diagnosed with ocular myasthenia. Funding Source - FDA OOPD | Cancer, Lupus, Myasthénie, Myopathies, SEP | Phase 3 | À vérifier | China | À vérifier |
| Prednisone+TofacitinibThis will be efficacy and safety of Induction and Tapering Therapy with Tofacitinib and Glucocorticoid in patients with Polymyalgia Rheumatica (ITTG PMR): An open-label 52-week randomized controlled trial | Myopathies | Phase 3 | À vérifier | China | À vérifier |
| PrednisoneThe purpose of this study is to evaluate the efficacy and tolerability of prednisone in patients diagnosed with ocular myasthenia. Funding Source - FDA OOPD | Myasthénie | Phase 3 | À vérifier | United States, Canada | À vérifier |
| PrednisoneThe purpose of this study is to evaluate the efficacy and tolerability of prednisone in patients diagnosed with ocular myasthenia. Funding Source - FDA OOPD | Myopathies | Phase 4 | À vérifier | Italy | À vérifier |
| Prednisone+TofacitinibThis will be efficacy and safety of Induction and Tapering Therapy with Tofacitinib and Glucocorticoid in patients with Polymyalgia Rheumatica (ITTG PMR): An open-label 52-week randomized controlled trial | Myopathies | Phase 3 | À vérifier | China | À vérifier |
Essais cliniques
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Prednisone+Tofacitinib | Myopathies | Phase 3 | NCT06172361 | ITTGPMR — Induction and Tapering Therapy With Tofacitinib and Glucocorticoid in Patients With Polymyalgia Rheumatica | COMPLETED |
| Prednisone | Myopathies | Phase 4 | NCT01169597 | Short Term Efficacy of a Starting Dose of 12.5 mg of Prednisone in Polymyalgia Rheumatica Patients | COMPLETED |
| Prednisone | Myasthénie | Phase 3 | NCT00995722 | Efficacy of Prednisone In the Treatment of Ocular Myasthenia | TERMINATED |
Publications
5| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Prednisone | Prevalence and Clinical Correlates of Sarcopenia and Malnutrition in Lung Transplant Recipients Using EWGSOP2 and GLIM Criteria. | Nutrients | ||
| Prednisone | Sympathetic ophthalmia induced by vitrectomy for endogenous fungal endophthalmitis: a case report and literature review. | Frontiers in medicine | ||
| Prednisone | Pneumocystis jirovecii pneumonia and prophylaxis in patients with solid tumours: a narrative review. | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | ||
| Prednisone | Isolated trochlea and triquetrum fractures in an immunocompromised adolescent after a ground-level fall. | BMJ case reports | ||
| Prednisone | Multi-omics-guided diagnosis and treatment of toxoplasma retinochoroiditis with co-infection: a case report. | BMC ophthalmology |